Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Non-Current Assets (2023 - 2026)

Solventum posted quarterly Non-Current Assets of $10.5 billion for Q1 2026, down 8.37% year-on-year from $11.5 billion in Q1 2025, and up 0.76% on a QoQ basis from $10.4 billion in Q4 2025.

Solventum (SOLV) has 4 years of Non-Current Assets data on file, last reported at $10.5 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 8.37% year-over-year to $10.5 billion; the trailing twelve-month figure through Mar 2026 stood at $42.4 billion (down 6.42% YoY), and the FY2025 full-year result was $10.4 billion, down 6.9% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $10.5 billion, up from $10.4 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $11.9 billion in Q2 2025 and bottomed at $9.6 billion in Q3 2025.
  • The 4-year median for Non-Current Assets is $11.3 billion (2024), against an average of $11.0 billion.
  • Peak annual rise in Non-Current Assets reached 5.8% in 2025, while the deepest fall reached 16.02% in 2025.
  • A 4-year view of Non-Current Assets shows it stood at $11.4 billion in 2023, then retreated by 1.89% to $11.2 billion in 2024, then slipped by 6.9% to $10.4 billion in 2025, then gained by 0.76% to $10.5 billion in 2026.
  • The last three Non-Current Assets figures came in at $10.5 billion (Q1 2026), $10.4 billion (Q4 2025), and $9.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 11.30 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 42.82 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 4.72 Bn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 2.28 Bn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 10.51 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 10.29 Bn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 3.66 Bn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 13.00 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 3.33 Bn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 1.77 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.51 Bn
Dec 31, 2025 10.44 Bn
Sep 30, 2025 9.57 Bn
Jun 30, 2025 11.87 Bn
Mar 31, 2025 11.47 Bn
Dec 31, 2024 11.21 Bn
Sep 30, 2024 11.39 Bn
Jun 30, 2024 11.22 Bn
Mar 31, 2024 11.35 Bn
Dec 31, 2023 11.42 Bn